Gastritis and gastric atrophy

Current Opinion in Gastroenterology

Volumn 24, Issue 6, 2008, Pages 682-686

  El Zimaity, Hala ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Atrophy; Gastritis; Staging

Indexed keywords

PROTON PUMP INHIBITOR;

AUTOIMMUNE DISEASE; CANCER RISK; DISEASE CLASSIFICATION; DUODENUM ULCER; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; PERNICIOUS ANEMIA; REVIEW; STOMACH ATROPHY; STOMACH CARCINOMA; STOMACH DISEASE; STOMACH ULCER;

ATROPHY; DISEASE PROGRESSION; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 55749100683     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328311d1cc     Document Type: Review

References (50)

1. Graham DY, Nurgalieva ZZ, El-Zimaity HM, et al. Noninvasive versus histologie detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 2006; 4:306-314.
2. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56:631-636.
3. Rugge M, Kim JG, Mahachai V, et al. OLGA gastritis staging in young adults and country-specific gastric cancer risk, Int J Surg Pathol 2008; 16:50-54. In this study, gastritis score matched gastric cancer risk in different populations.
4. Stemmermann GN, Hayashi T. Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst 1968; 41:627-634.
5. Lambert R. Chronic gastritis. A critical study of the progressive atrophy of the gastric mucosa. Digestion 1972; 7:83-126.
6. Faber K. Chronic gastritis: its relation to achlorhydria and ulcer. Lancet 1927; 2:902-917.
7. Graham DY, Opekun A, Lew GM, et al. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 1991; 100:1571-1575.
8. Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 1991; 6:125-130.
9. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96 (Pt 2 Suppl 2):615-625.
10. Burstein M, Monge E, Leon-Barua R, et al. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol 1991; 13:154-156.
11. Meining A, Stolte M, Hatz R, et al. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch 1997; 431:11-15.
12. Malaty HM, Kim JG, El-Zimaity HM, et al. High prevalence of duodenal ulcer and gastric cancer in dyspeptic patients in Korea. Scand J Gastroenterol 1997; 32:751-754.
13. El-Zimaity HMT. Recent advances in histopathology of gastritis. Curr Diagn Pathol 2007; 13:340-348.
14. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-1181.
15. Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst 1970; 44:297-306.
16. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1:87-97.
17. Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia, Int J Cancer 1994; 57:324-329.
18. Savage A, Jones S. Histological appearances of the gastric mucosa 15-27 years after partial gastrectomy. J Clin Pathol 1979; 32:179-186.
19. Lewin KJ, Dowling F, Wright JP, et al. Gastric morphology and serum gastrin levels in pernicious anaemia. Gut 1976; 17:551-560.
20. Rubio CA. My approach to reporting a gastric biopsy. J Clin Pathol 2007; 60:160-166.
21. El-Zimaity HMT, Gutierrez O, Kim JG, et al. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001; 96:666-672.
22. Recavarren-Arce S, Leon-Barua R, Cok J, et al. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol Suppl 1991; 181:51-57.
23. Sipponen P. Gastric cancer: a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol Suppl 1994; 201:24-27.
24. Sipponen P. Atrophic gastritis as a premalignant condition. Ann Med 1989; 21:287-290.
25. Vaananen H, Vauhkonen M, Helske T, et al. Nonendoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15:885-891.
26. Sipponen P, Ranta P, Helske T, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002; 37:785-791.
27. El-Zimaity HM, Ota H, Graham DY, et al. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 2002; 94:1428-1436.
28. Siurala M, Sipponen P, Kekki M. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol Suppl 1985; 109:69-76.
29. Lamberts R, Creutzfeldt W, Struber HG, et al. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104:1356-1370.
30. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pyloriassociated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995; 90:1401-1406.
31. Moayyedi P, Wason C, Peacock R, et al. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter 2000; 5:206-214.
32. Kim HY, Kim YB, Park CK, et al. Co-existing gastric cancer and duodenal ulcer disease: role of Helicobacter pylori infection. Helicobacter 1997; 2:205-209.
33. Kirk RM, Jeffery PJ. Development of surgery for peptic ulcer: a review. J R Soc Med 1981; 74:828-830.
34. Faller G, Steininger H, Kranzlein J, et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 1997; 41:619-623.
35. Negrini R, Savio A, Poiesi C, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111:655-665.
36. Alkout AM, Blackwell CC, Weir DM, et al. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis(a), and Lewis(b) antigens. Gastroenterology 1997; 112:1179-1187.
37. Wirth HP, Yang M, Peek RM Jr, et al. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997; 113:1091-1098.
38. Ma JY, Borch K, Mardh S. Human gastric H,K-adenosine triphosphatase beta-subunit is a major autoantigen in atrophic corpus gastritis. Expression of the recombinant human glycoprotein in insect cells. Scand J Gastroenterol 1994; 29:790-794.
39. Claeys D, Faller G, Appelmelk BJ, et al. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998; 115:340-347.
40. Sakai H, Eishi Y, Li XL, et al. PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 2004; 53:323-330.
41. Tatematsu M, Ichinose M, Miki K, et al. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990; 40:494-504.
42. Ricuarte O, Gutierrez O, Cardona H, et al. Atrophic gastritis in young children and adolescents. J Clin Pathol 2005; 58:1189-1193.
43. DeLuca VA Jr. Helicobacter pylori gastric atrophy and pernicious anemia. Gastroenterology 1992; 102:744-745.
44. Chlumska A, Boudova L, Benes Z, et al. Autoimmune gastritis. A clinico-pathologic study of 25 cases. Cesk Patol 2005; 41:137-142.
45. Whitehead R, Truelove SC, Gear MW. The histologlcal diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972; 25:1-11.
46. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6:209-222.
47. El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 2001; 54:679-683.
48. Fock KM, Talley NJ, Pass R, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23:351-365. In this manuscript, consensus guidelines for H. pylori screening and eradication were established.
49. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008; 103:510-514.
50. Satoh K, Osawa H, Yoshizawa M, et al. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008; 13:225-229.